News for Actinium Pharmaceuticals Stock (ATNM)

Actinium Pharmaceuticals, Inc. Is Being Investigated For Securities Law Violations And Impacted Stockholders Are Urged To Reach Out To The Schall Law Firm

Accesswire • 09/29/24

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

Accesswire • 09/29/24

The Schall Law Firm Invites Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

Accesswire • 09/28/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Violating Securities Laws And Impacted Stockholders Are Urged To Contact The Schall Law Firm

Accesswire • 09/27/24

The Schall Law Firm Invites Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud

Accesswire • 09/26/24

Actinium Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Accesswire • 09/25/24

The Schall Law Firm Invites Investors To Join A Securities Fraud Inquiry Into Actinium Pharmaceuticals Inc

Accesswire • 09/24/24

Actinium Pharmaceuticals, Inc. Is Being Investigated By The Schall Law Firm For Violating Securities Laws And Shareholders Should Reach Out

Accesswire • 09/23/24

The Schall Law Firm Is Looking Into Actinium Pharmaceuticals Inc For Possible Securities Fraud And Investors With Losses Are Urged To Join The Inquiry

Accesswire • 09/22/24

Actinium Pharmaceuticals, Inc. May Have Violated Securities Laws And The Schall Law Firm Encourages Impacted Shareholders To Reach Out

Accesswire • 09/21/24

Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Actinium Pharmaceuticals Inc For Securities Fraud

Accesswire • 09/20/24

Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical Oncology

PRNewsWire • 09/20/24

The Schall Law Firm Is Looking Into Actinium Pharmaceuticals, Inc.'s Possible Securities Law Violations And Stockholders With Losses Should Reach Out

Accesswire • 09/19/24

Actinium Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm

Accesswire • 09/18/24

The Schall Law Firm Seeks Shareholder Participation In An Inquiry Into Actinium Pharmaceuticals, Inc. For Violating Securities Laws

Accesswire • 09/17/24

Actinium Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire • 09/16/24

The Schall Law Firm Wants Shareholders To Partake In An Inquiry Into Actinium Pharmaceuticals, Inc. For Securities Related Infractions

Accesswire • 09/15/24

Actinium Pharmaceuticals Inc Is Being Investigated By The Schall Law Firm For Possible Fraud And Investors With Losses Should Reach Out

Accesswire • 09/14/24

Shareholders Are Encouraged To Join The Schall Law Firm's Inquiry In Actinium Pharmaceuticals, Inc. For Securities Law Violations

Accesswire • 09/13/24

The Schall Law Firm Is Looking Into Whether Actinium Pharmaceuticals Inc Committed Securities Fraud And Investors With Losses Can Reach Out

Accesswire • 09/12/24

Stakeholders In Actinium Pharmaceuticals Inc. Are Encouraged To Contribute To The Schall Law Firm's Inquiry

Accesswire • 09/11/24

IBA's joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production

GlobeNewsWire • 09/11/24

Actinium Pharmaceuticals Inc May Have Violated Securities Regulations And The Schall Law Firm Invites Investors To Help With An Investigation

Accesswire • 09/10/24

Shareholders Are Encouraged To Join The Schall Law Firm In An Inquiry Into Whether Actinium Pharmaceuticals, Inc. Committed Securities Fraud

Accesswire • 09/09/24

Securities Laws May Have Been Violated By Actinium Pharmaceuticals Inc And The Schall Law Firm Invites Investors To Join An Investigation

Accesswire • 09/07/24